background

  • Meeting
  • spacer

    • CONFERENCE PROGRAMME

    • spacer
        • Tuesday, 20th October 2009
        • 16:00 to 18:00
        • spacer
        • Registration of delegates

    • spacer
        • Wednesday, 21st October 2009
        • 18:45 to 21:00
        • spacer
        • AIMA cordially invites all speakers and delegates to a cocktail gathering

    • spacer
        • Friday, 23rd October 2009
        • 18:45 to 21:30
        • spacer
        • AIMA cordially invites all speakers and delegates to a closing dinner.

    • spacer
  • Papers to be presented at the 7th Scientific Conference of AIMA from 21st to 23rd October 2009

    • UNDERWRITING ISSUES:

    • spacer
      • Topics to be discussed
      • Speakers
    • spacer
      • Current and future prospects of the Life Insurance Industry in Malaysia
        • To be announced

      • What is new about Syndrome X - Its impact on the selection of life risk
        • Dr. Andreas Armuss
        • Medical Consultant, Munich Re, Germany

      • Underwriting depression etc. - A minefield for the Underwriters and Claims managers?"
        • Dr. Detloff Rump
        • Regional Chief Underwriter-Asia
        • Gen Re LifeHealfh, Hong Kong

      • What is new with regards to imaging techniques in cardiology- their predictive values
        • Dr. Fabrice Chouty
        • CMO & Consultant Cardiologist
        • Hannover Re, France

      • HbA1c as a marker for the control of Diabetes Mellitus-News from a clinical laboratory
        • Dr. PK Menon
        • Senior Medical Director
        • Quest Diagnostics

        • The genetics of critical illness- an overview of this issue by a Medical Scientist.
        • Mr. Aamer Fattah
        • Medical Scientist, Technical Consultant (Insurance) Sydney, Australia.

      • Morbidity and Mortality Trends of Major Diseases-Past and Future
        • Dr. Heinrich Duhme
        • Medical Consultant, Education and Training,
        • Life Services, Hannover Life Re Germany

      • Professional development in life insurance and the need for adequate training and education
        • Mr. Gordon Cramer
        • Senior Underwriter/Non-Disclosure
        • Specialist -FP Operations VIC

      • Predictive value of the resting ECG - Does it have any role as a screening tool in Insurance medicine?
        • Dr. Fajah S. Peshi
        • President AIMA & Regional CMO,
        • Gen Re Life Health

      • Extended Personal Accident Products - The possibility of New Product Lines in Asian Markets
        • Dr. Nicola-Alexander Sittaro
        • Director/ Chief Medical Officer (Cardiologist)
        • Life Services, Hannover Life Re Germany

      • Update - Global UW and Medical Advances
        • Dr. John Lefebre
        • Chief Regional Medical Director Europe
        • South Africa and India, RGA International

      • The Current Scope of Evidence Based Underwriting
        • Ms. Melinda Moro
        • Principal Underwriter. Gen Re LifeHealth
        • Sydney, Australia

      • Urine and Renal Testing - all about eGFR, hematuria and proteinufia
        • Dr. John Lefebre
        • Chief Regional Medical Director Europe,
        • South Africa and India, RGA International

      • An update on "New Laboratory Tests"
        • Ms. Amanda Kuster
        • Director, Head of Underwriting, Asia
        • Swiss Re, Singapore

      • Capital Market Crisis - Opportunities for a Life Reinsurer in Asia
        • Mr. Frank Miehe
        • Senior Marketing Actuary,
        • Hannover Life Re Germany

      • A laboratory based algoririthm for the selection of life risk and underwriting - Is this feasible?
        • Dr. PK Menon
        • Senior Medical Director
        • Quest Diagnostics

      • What is new about Prostate cancer ?- Issues that are related to investigations as well as risk selection
        • Dr. Steven Zimmerman
        • Vice President, Chief Medical Director
        • Transamerica Reinsurance

      • Critical Illness Product- Issues related to the new tiered trends of the product that we see today
        • Ms. Lorna McLaren
        • Marketing Actuary, Gen Re Life Health

      • LVH as a risk factor-Its long term prognosis and impact on risk selection
        • Dr. Andreas Armuss
        • Medical Consultant, Munich Re, Germany

    • PAPERS ON CLAIMS ISSUES TO BE PRESENTED

    • spacer
      • Topics to be discussed
      • Speakers
    • spacer
      • The intention of the contract - an aid to realistic claims handling
        • Mr. Colin Bradford
        • Operations Consultant,
        • Gen Re LifeHeafth

      • Claims rejects- Are you fully prepared for legal action?
        • Ms. Kalpana Sampat
        • Chief-Internal Audit, Legal & Risk Control
        • ICCI Prudential,Mumbai,India

      • Claims Intelligence -A potpourri of issues relating to medical insurance claims.
        • Dr. Nilima Kadambi
        • Vice president, Claims Manager,
        • Swiss Re

      • Overview of Takaful business - how claims and underwriting differ from non Takaful business.
        • Marcel Papp
        • Director, Head of Re-Takafur, Asia
        • Swiss Re

      • Fraud, behaviorism and the fraud triangle - Issues discussed by a Medical Scientist
        • Mr. Aamer Fattah
        • Medical Scientist, Technical Consultant (Insurance),Sydney, Australia.

      • Borderline Claims - Case studies of challenging borderline medical claims
        • Ms. Tina Paap
        • VP, Claims Australia & New Zealand
        • RGA Asia Pacific Ptv Ltd

      • Case Study - Three interesting and controversial claims will be discussed during this session
        • Ms. Ivanka Williams
        • Regional Risk Manager
        • Allianz Reinsurance Asia Pacific

      • Challenges in establishing and contracting direct billing health care provider network.
        • Mr. Chen Tar Wei
        • Senior Advisor. Medilink -Beijing, China